Your browser doesn't support javascript.
loading
Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System Lymphoma.
Wada-Shimosato, Yuko; Ikeda, Junji; Tsujimoto, Shin-Ichi; Sasaki, Koji; Yanagimachi, Masakatsu; Kajiwara, Ryosuke; Shiba, Norio; Murata, Hidetoshi; Kawahara, Nobutaka; Yamanaka, Shoji; Tanoshima, Reo; Ito, Shuichi.
Affiliation
  • Wada-Shimosato Y; Departments of Pediatrics.
  • Ikeda J; Departments of Pediatrics.
  • Tsujimoto SI; Departments of Pediatrics.
  • Sasaki K; Departments of Pediatrics.
  • Yanagimachi M; Departments of Pediatrics.
  • Kajiwara R; Departments of Pediatrics.
  • Shiba N; Departments of Pediatrics.
  • Murata H; Neurosurgery.
  • Kawahara N; Neurosurgery.
  • Yamanaka S; Pathology, Yokohama City University School of Medicine, Yokohama, Japan.
  • Tanoshima R; Departments of Pediatrics.
  • Ito S; Departments of Pediatrics.
J Pediatr Hematol Oncol ; 41(7): 571-573, 2019 10.
Article in En | MEDLINE | ID: mdl-30124546
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Lymphoma, Large B-Cell, Diffuse / Rituximab / Antineoplastic Agents, Immunological Type of study: Prognostic_studies Limits: Child / Humans / Male Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Lymphoma, Large B-Cell, Diffuse / Rituximab / Antineoplastic Agents, Immunological Type of study: Prognostic_studies Limits: Child / Humans / Male Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2019 Document type: Article Country of publication: United States